Amount Raised
$52 Million
Round Type
Series A
CambridgeOtherBiotechnologyHealth CareVenture CapitalInvestors
Description
Rgenta Therapeutics Inc. announced today that it closed a $52 million Series A round led by AZ-CICC Healthcare Investment Fund with participation from all existing investors and new investors including Korean Investment Partners, Delos Capital. Rgenta Therapeutics is focusing on developing RNA-targeting medicines for historically undruggable disease targets.
Quick answer
Rgenta Therapeutics, Inc. raised $52 Million in a Series A round, dated November 29, 2022. Investors: Delos Capital, Korean Investment Partners and Az Cicc Healthcare Investment Fund. Rgenta Therapeutics, Inc. is based in Cambridge, Massachusetts, United States.
- How much did Rgenta Therapeutics, Inc. raise?
- Rgenta Therapeutics, Inc. raised $52 Million in a Series A round on November 29, 2022.
- Who invested in Rgenta Therapeutics, Inc?
- Delos Capital, Korean Investment Partners and Az Cicc Healthcare Investment Fund are named as investors in this round.
- What does Rgenta Therapeutics, Inc. do?
- Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders.
- Where is Rgenta Therapeutics, Inc. based and how big is it?
- Rgenta Therapeutics, Inc. is based in Cambridge, Massachusetts, United States. Fundz records about 33 employees.
- Who are the decision-makers at Rgenta Therapeutics, Inc?
- Fundz holds 1 contact at Rgenta Therapeutics, Inc., including the Senior Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Venture Capital and Biotechnology around the same time
Companies in the same sectors as Rgenta Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- DeepLook Medical raised $1.5M (Seed) on January 13, 2023.
- LinusBio raised $16M (Funding Round) on January 12, 2023.
- Wheeler Bio raised an undisclosed amount (Funding Round) on January 12, 2023.
- MPC Therapeutics raised an undisclosed amount (Seed) on January 11, 2023.
- Vero Biotech Inc. raised $30M (Funding Round) on January 11, 2023.
- Telesair raised $22M (Series A) on January 10, 2023.
Who to call at Rgenta Therapeutics, Inc., and when
A new round usually means Rgenta Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Rgenta Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Rgenta Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Rgenta Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Rgenta Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansRgenta Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.